Lexington-Fayette Urban County Government - File #: 0460-23

• File #: 0460-23
• Version: 2
• Name: Request Council authorization to establish Adapt Pharma as a sole source provider of nasal Narcan for the SAMSHA FY2022 Congressional Directive Spending Projects Award for the Barrier Free Re-Entry and Recovery Initiative in the Division of Social Service
• Type: Resolution
• Status: Approved
• File created: 4/24/2023
• In control: Urban County Council
• On agenda: 5/11/2023
• Final action: 5/11/2023
• Enactment date: 5/11/2023
• Enactment #: R-263-2023
• Title: A Resolution establishing Adapt Pharma as a sole source provider of nasal Narcan for the United States Substance Abuse and Mental Health Services Administration (SAMSHA) FY2022 Congressional Directive Spending Projects award for the Barrier Free Re-Entry and Recovery Initiative for the Dept. of Social Services, and authorizing the Mayor, or her designee, on behalf of the Urban County Government, to execute any necessary Agreements with Adapt Pharma related to the procurement of these goods, at a cost not to exceed $171,570. [Dept. of Social Services, Allen-Bryant]

Date	Ver.	Action By	Action	Result
5/11/2023	2	Urban County Council	Received First Reading
5/11/2023	2	Urban County Council	Suspended Rules for Second Reading	Pass
5/11/2023	2	Urban County Council	Approved	Pass
5/2/2023	2	Urban County Council Work Session	Approved and Referred to Docket	Pass

Title
A Resolution establishing Adapt Pharma as a sole source provider of nasal Narcan for the United States Substance Abuse and Mental Health Services Administration (SAMSHA) FY2022 Congressional Directive Spending Projects award for the Barrier Free Re-Entry and Recovery Initiative for the Dept. of Social Services, and authorizing the Mayor, or her designee, on behalf of the Urban County Government, to execute any necessary Agreements with Adapt Pharma related to the procurement of these goods, at a cost not to exceed $171,570. [Dept. of Social Services, Allen-Bryant]

Summary
Authorization to establish Adapt Pharma as a sole source provider of nasal Narcan for the SAMSHA FY2022 Congressional Directive Spending Projects Award for the Barrier Free Re-Entry and Recovery Initiative for the Department of Social Services at a cost not to exceed $171,570. Funds are Budgeted. (L0460-23) (Baker/Allen-Bryant)
Budgetary Implications: Yes
Advance Document Review:
Law: N/A
Risk Management: N/A
Fully Budgeted: Yes
Account Number: 3190-606105-0001-75101
This Fiscal Year Impact: $171,570.00
Annual Impact: $0
Project: SMHSABFREE_2023
Activity: FED_GRANT
Budget Reference: 2023
Current Balance: $171,600
Body
BE IT RESOLVED BY THE COUNCIL OF THE LEXINGTON-FAYETTE URBAN COUNTY GOVERNMENT:
Section 1 - That Adapt Pharma be and hereby is established as a sole source provider of nasal Narcan for the United States Substance Abuse and Mental Health Services Administration (SAMSHA) FY 2022 Congressional Directive Spending Projects Award for the Barrier-Free Re-Entry and Recovery Initiative for the Department of Social Services, and authorizing the Mayor, or her designee, on behalf of the Lexington-Fayette Urban County Government, to execute any necessary Agreements with Adapt Pharma related to the procurement of these goods.
Section 2 - That an amount, not to exceed the sum of $171,570.00, be and hereby is approved for payment to Adapt Pharma, from account #3190-606105-75101, pu...